Literature DB >> 32003417

Neuropsychiatric Symptoms and Risk Factors in Mild Cognitive Impairment: A Cohort Investigation of Elderly Patients.

A-N Yang1, X-L Wang, H-R Rui, H Luo, M Pang, X-M Dou.   

Abstract

BACKGROUND: Neuropsychiatric symptoms (NPS) have been shown to affect the progression and development of Alzheimer's disease (AD) in the elderly. However, the published data are still controversial and limited in large cohort-based NPS study. AIM: To explore the potential relationship between NPS and mild cognitive impairment (MCI) among the elderly of Chinese community.
METHODS: A total of 465 Chinese community-dwelling elderly (age ≥ 60 years) with mild cognitive impairment (MCI) were recruited into this investigation. At baseline, enrolled participants were assessed for Clinical Dementia Rating (CDR), mini-psychiatric examination. They were also subjected to categorical language fluency test, list learning and delayed recall. We assessed the NPS severity by Neuropsychological Inventory (NPI). The global cognitive status (GCS) of the participants at the end of the 3-year study period were measured with the CDR.
RESULTS: Approximately 41.6% of subjects had 1 or more NPS (total NPI score ≥ 1) at baseline. The most common NPSs were nocturnal behavior (20.8%), depression (17.3%), apathy (12.7%) and anxiety (13.2%). At the end of 3-year follow-up, 26.9% of baseline depressed patients developed AD, while 15.2% of baseline non-depressed patients developed AD (χ2 = 4.86, P=0. 04). Abnormal motor behavior was significantly correlated with cognitive deterioration as well (χ2 = 5.75, P=0. 03). Logistic regression analysis revealed that depression was considered as a risk factor for AD progression at baseline (95% CI: 1.12-5.67, OR=2.37, P=0.03).
CONCLUSIONS: Depression may be an independent factor representing early neurodegeneration in elder patients with MCI. Further studies are warranted to assess whether effective management of NPS promotes the cognitive functions.

Entities:  

Keywords:  Alzheimer’s disease (AD); Neuropsychiatric Symptoms (NPS); mild cognitive impairment (MCI)

Mesh:

Year:  2020        PMID: 32003417     DOI: 10.1007/s12603-020-1312-9

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN: 1279-7707            Impact factor:   4.075


  25 in total

1.  Network Disruption in the Preclinical Stages of Alzheimer's Disease: From Subjective Cognitive Decline to Mild Cognitive Impairment.

Authors:  David López-Sanz; Pilar Garcés; Blanca Álvarez; María Luisa Delgado-Losada; Ramón López-Higes; Fernando Maestú
Journal:  Int J Neural Syst       Date:  2017-08-16       Impact factor: 5.866

2.  Risk of Conversion to Dementia in a Mild Behavioral Impairment Group Compared to a Psychiatric Group and to a Mild Cognitive Impairment Group.

Authors:  Fernando E Taragano; Ricardo F Allegri; Silvina L Heisecke; María I Martelli; Mónica L Feldman; Viviana Sánchez; Virginia A García; Graciela Tufro; Diego M Castro; Patricio Perez Leguizamón; Verónica Guelar; Eva Ruotolo; Cecilia Zegarra; Carol Dillon
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

3.  Accelerated Age-Dependent Hippocampal Volume Loss in Parkinson Disease With Mild Cognitive Impairment.

Authors:  Christine B Schneider; Markus Donix; Katharina Linse; Annett Werner; Mareike Fauser; Lisa Klingelhoefer; Matthias Löhle; Rüdiger von Kummer; Heinz Reichmann; Alexander Storch
Journal:  Am J Alzheimers Dis Other Demen       Date:  2017-05-04       Impact factor: 2.035

4.  Alexithymia in people with subjective cognitive decline, mild cognitive impairment, and mild Alzheimer's disease.

Authors:  Mehmet Yuruyen; Fundan Engin Akcan; Gizem Cetiner Batun; Gozde Gultekin; Mesut Toprak; Hakan Yavuzer; Murat Emul
Journal:  Aging Clin Exp Res       Date:  2017-01-21       Impact factor: 3.636

Review 5.  Mild cognitive impairment as a diagnostic entity.

Authors:  R C Petersen
Journal:  J Intern Med       Date:  2004-09       Impact factor: 8.989

Review 6.  The starving brain: Overfed meets undernourished in the pathology of mild cognitive impairment (MCI) and Alzheimer's disease (AD).

Authors:  Kelly J Gibas
Journal:  Neurochem Int       Date:  2017-09-09       Impact factor: 3.921

7.  Anosognosia Is an Independent Predictor of Conversion From Mild Cognitive Impairment to Alzheimer's Disease and Is Associated With Reduced Brain Metabolism.

Authors:  Philip Gerretsen; Jun Ku Chung; Parita Shah; Eric Plitman; Yusuke Iwata; Fernando Caravaggio; Shinichiro Nakajima; Bruce G Pollock; Ariel Graff-Guerrero
Journal:  J Clin Psychiatry       Date:  2017 Nov/Dec       Impact factor: 4.384

8.  Prevalence of Neuropsychiatric Symptoms across the Declining Memory Continuum: An Observational Study in a Memory Clinic Setting.

Authors:  Meiyan Zhang; Huali Wang; Tao Li; Xin Yu
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2012-04-27

9.  Quantifying the effect of body mass index, age, and depression severity on 24-h activity patterns in persons with a lifetime history of affective disorders.

Authors:  Nahid Banihashemi; Rébecca Robillard; Jean Yang; Joanne S Carpenter; Daniel F Hermens; Sharon L Naismith; Zoe Terpening; Django White; Elizabeth M Scott; Ian B Hickie
Journal:  BMC Psychiatry       Date:  2016-09-09       Impact factor: 3.630

10.  Association of imaging abnormalities of the subcallosal septal area with Alzheimer's disease and mild cognitive impairment.

Authors:  C L Gan; M J O'Sullivan; C Metzler-Baddeley; S Halpin
Journal:  Clin Radiol       Date:  2017-08-30       Impact factor: 2.350

View more
  1 in total

Review 1.  Risk of conversion from mild cognitive impairment to dementia in low- and middle-income countries: A systematic review and meta-analysis.

Authors:  Andrea M McGrattan; Eduwin Pakpahan; Mario Siervo; Devi Mohan; Daniel D Reidpath; Matthew Prina; Pascale Allotey; Yueping Zhu; Chen Shulin; Jennifer Yates; Stella-Maria Paddick; Louise Robinson; Blossom C M Stephan
Journal:  Alzheimers Dement (N Y)       Date:  2022-03-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.